We firstly detected the expression of the CRC stemness markers CD44 and CD133 by immunofluorescence (IF) assay and Oct4, Nanog, and SOX2 by immunohistochemistry (IHC) assay in metastatic CRC liver tissues. The gene discussed is CD44; the disease is colorectal carcinoma.